Detalhe da pesquisa
1.
Broad humoral immunity generated in mice by a formulation composed of two antigens from the Delta variant of SARS-CoV-2.
Arch Virol
; 168(7): 190, 2023 Jun 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37351679
2.
A heterologous prime-boost strategy for immunization against Dengue virus combining the Tetra DIIIC subunit vaccine candidate with the TV005 live-attenuated tetravalent vaccine.
J Gen Virol
; 100(6): 975-984, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31090533
3.
A Tetravalent Formulation Based on Recombinant Nucleocapsid-like Particles from Dengue Viruses Induces a Functional Immune Response in Mice and Monkeys.
J Immunol
; 197(9): 3597-3606, 2016 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27683751
4.
A dose-response study in mice of a tetravalent vaccine candidate composed of domain III-capsid proteins from dengue viruses.
Arch Virol
; 162(8): 2247-2256, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28393307
5.
A novel tetravalent formulation combining the four aggregated domain III-capsid proteins from dengue viruses induces a functional immune response in mice and monkeys.
Int Immunol
; 27(8): 367-79, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25795768
6.
Could an experimental dengue virus infection fail to induce solid immunity against homologous viral challenge in non-human primates?
Arch Virol
; 161(2): 465-70, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26590068
7.
The protein DIIIC-2, aggregated with a specific oligodeoxynucleotide and adjuvanted in alum, protects mice and monkeys against DENV-2.
Immunol Cell Biol
; 93(1): 57-66, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25178969
8.
Type I interferon signals in macrophages and dendritic cells control dengue virus infection: implications for a new mouse model to test dengue vaccines.
J Virol
; 88(13): 7276-85, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24741106
9.
A tetravalent dengue vaccine containing a mix of domain III-P64k and domain III-capsid proteins induces a protective response in mice.
Arch Virol
; 159(10): 2597-604, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24841761
10.
Generation and characterization of potential dengue vaccine candidates based on domain III of the envelope protein and the capsid protein of the four serotypes of dengue virus.
Arch Virol
; 159(7): 1629-40, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24420159
11.
The Nucleocapsid Protein of SARS-CoV-2, Combined with ODN-39M, Is a Potential Component for an Intranasal Bivalent Vaccine with Broader Functionality.
Viruses
; 16(3)2024 03 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38543783
12.
Purified and highly aggregated chimeric protein DIIIC-2 induces a functional immune response in mice against dengue 2 virus.
Arch Virol
; 158(1): 225-30, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22983185
13.
Recombinant protein based on domain III and capsid regions of zika virus induces humoral and cellular immune response in immunocompetent BALB/c mice.
Vaccine
; 41(40): 5892-5900, 2023 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37599141
14.
Cross-Reactive Profile Against Two Conserved Coronavirus Antigens in Sera from SARS-CoV-2 Hybrid and Vaccinated Immune Donors.
Viral Immunol
; 36(3): 222-228, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36735580
15.
Recombinant nucleocapsid-like particles from dengue-2 induce functional serotype-specific cell-mediated immunity in mice.
J Gen Virol
; 93(Pt 6): 1204-1214, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22398317
16.
The serogroup A capsular polysaccharide from Neisseria meningitidis enhances the cell-mediated immunity and the protective capacity induced by a dengue fusion protein in mice.
Arch Virol
; 157(5): 987-91, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22350649
17.
Recombinant nucleocapsid-like particles from dengue-2 virus induce protective CD4+ and CD8+ cells against viral encephalitis in mice.
Int Immunol
; 21(10): 1175-83, 2009 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-19692540
18.
Nucleocapsid-like particles of dengue-2 virus enhance the immune response against a recombinant protein of dengue-4 virus.
Arch Virol
; 155(10): 1587-95, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20640909
19.
In vitro assembly of nucleocapsid-like particles from purified recombinant capsid protein of dengue-2 virus.
Arch Virol
; 154(4): 695-8, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19305942
20.
Dengue-4 envelope domain III fused twice within the meningococcal P64k protein carrier induces partial protection in mice.
Biotechnol Appl Biochem
; 52(Pt 4): 265-71, 2009 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-18636968